5 November 2018
The Centre for Psychiatric Neuroscience and the CHUV-Department of General Psychiatry have just published the results of a study suggesting the protective effects of antioxidant treatment on the brains of young adults suffering from psychosis. For several years, the Centre Read more…
4 November 2018
Two units of the Department of Psychiatry, in partnership with the Harvard Medical School, have tried innovative treatment in patients who have recently developed psychosis. Their results were published in the journal Schizophrenia Bulletin. The Schizophrenia Research Unit of the Read more…
27 August 2018
Philippe Conus, ordinary professor at the FBM-UNIL and head of the General Psychiatry Department of the CHUV, has been elected vice-president for Europe of the IEPA-Early Intervention in Mental Health, an international scientific society that aims to promote early intervention Read more…
1 August 2018
As he receives the Alphen Award for his global clinical approach, Philippe Conus tells Synapsy about the rich and novel path that led him to psychiatry. Between music and psychiatry Philippe Conus dreamt of a career as a jazz clarinetist Read more…
Kim Do receiving the 2018 SIRS Outstanding Basic Science Award, and Professor René Kahn. Kim Do has devoted most of her career to understanding the origins, effects and potential opportunities linked to an observation she made in patients suffering from Read more…
NAC improves fornix integrity in parallel to the increase of brain glutathione and cognition improvement. 6-month longitudinal gFA changes : NAC vs Placebo. Coronal, sagittal and axial views show voxel-wise analysis results indicating location (body of the fornix) of time Read more…
30 November 2017
The Schizophrenia Research Unit has identified a common genetic mechanism for schizophrenia and autism, which induces impaired cognitive performance of the brain. The Schizophrenia Research Unit (URS) of the Center for Psychiatric Neuroscience (Prof. Kim Do-Cuénod) of the CHUV Department Read more…
27 November 2017
A joint team between the Lausanne CHUV and Harvard American University paves the way for a new neuroprotective treatment for schizophrenia. Three questions to Kim Do, head of the Center for Psychiatric Neuroscience at the CHUV-Prilly: You have successfully tested Read more…
18 November 2017
The Centre of Psychiatric Neurosciences (CNP) schizophrenia research Unit (Prof. Kim Do Cuénod) and the CHUV General Psychiatry Department (Prof. Philippe Conus), in partnership with the Harvard Medical School of Boston (Prof. Larry Seidman), have conducted a clinical trial with Read more…
